66 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 May 24
Current report (foreign)
4:03pm
expires. Each director’s term continues until the election and qualification of his or her successor, or his or her earlier death, resignation … is duly elected and qualified or until his earlier death, resignation or removal.”
“RESOLVED, to re-elect Dr. Adi Mor to serve as a director
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jan 24
Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary
7:00am
in PSC, Which Often Results in Liver Transplant or Death and Lacks Any FDA-Approved Treatments—
TEL AVIV, Israel ─ January 3, 2024 ─ Chemomab
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jul 23
Current report (foreign)
3:49pm
and qualification of his or her successor, or his or her earlier death, resignation or removal. Any increase or decrease in the number of directors … or until his earlier death, resignation or removal.”
“RESOLVED, to re-elect Dr. Claude Nicaise to serve as a director of the Company to hold office
8-K
a2n8kyxr
8 Jun 22
Submission of Matters to a Vote of Security Holders
6:01am
8-K
EX-99.1
rml4ggcx
10 Nov 21
Regulation FD Disclosure
5:06pm
8-K
EX-99.1
kcthbl0wbv1syxeo5
25 Oct 21
Regulation FD Disclosure
4:02pm
8-K
EX-99.2
375gd 12mh5t81qd4
2 Sep 21
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief
7:11am
8-K/A
mm275yn 9qc
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am